Sleep Kids
Products
Dosage instructions
- Dosage amount:
1 Capsule
once per day
Additional notes
"Only one randomized, double-blind, placebo-controlled trial to evaluate the effect of 200 mg of L-theanine twice a day for six weeks on sleep quality of 98 children (aged 8–12 years), with a diagnosis of attention-deficit/hyperactivity disorder (ADHD), has been published [36]. In the group taking L-theanine, actigraphic sleep and sleep efficiency scores improved with respect to the placebo group. No adverse events were reported, suggesting that a daily dosage of 400 mg of L-theanine can safely and effectively improve sleep quality in children with ADHD. Lyon, M.R.; Kapoor, M.P.; Juneja, L.R. The effects of L-theanine (Suntheanine®) on objective sleep quality in boys with attention deficit hyperactivity disorder (ADHD): A randomized, double-blind, placebo-controlled clinical trial. Altern. Med. Rev. 2011, 16, 348–354."
Sign up for exclusive store pricing
Dosage instructions
- Dosage amount:
10 Drops
morning
Additional notes
"ONLY give in the MORNING Bruni et al. [31] in 2004 were among the first to carry out an open pharmacological trial to verify the efficacy of L-5-hydroxyTRP (L-5-HTP) in 45 children (aged 3.2–10.6 years) with sleep terrors divided in two groups, one taking 2 mg/kg per day of L-5-HTP at bedtime for 20 consecutive days and the control group in the watchful waiting without any treatment. Patients taking L-5-HTP decreased the number of episodes in 93.5% (29 out of 31) vs. 28.6% of the control group; the improvement was maintained after 6 months follow-up. Similarly, in a retrospective analysis of medical records, children aged 3 to 18 years with primary parasomnia that received L-TRP (daily dose range: 500–4500 mg, mean dose 2400 mg) experienced improvements in their parasomnia symptoms in 84% of cases, compared to only 47% of the non-treated group [35]. van Zyl, L.T.; Chung, S.A.; Shahid, A.; Shapiro, C.M. L-Tryptophan as Treatment for Pediatric Non-Rapid Eye Movement Parasomnia. J. Child Adolesc. Psychopharmacol. 2018, 28, 395–401."


